Life expectancy in 2040 : what do clinical experts expect?
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<record>
<leader>00000cab a2200000 4500</leader>
<controlfield tag="001">MAP20160034189</controlfield>
<controlfield tag="003">MAP</controlfield>
<controlfield tag="005">20161123173450.0</controlfield>
<controlfield tag="008">161117e20160905usa|||p |0|||b|eng d</controlfield>
<datafield tag="040" ind1=" " ind2=" ">
<subfield code="a">MAP</subfield>
<subfield code="b">spa</subfield>
<subfield code="d">MAP</subfield>
</datafield>
<datafield tag="084" ind1=" " ind2=" ">
<subfield code="a">6</subfield>
</datafield>
<datafield tag="245" ind1="1" ind2="0">
<subfield code="a">Life expectancy in 2040</subfield>
<subfield code="b">: what do clinical experts expect?</subfield>
<subfield code="c">Vladimir Canudas-Romo... [et al.]</subfield>
</datafield>
<datafield tag="520" ind1=" " ind2=" ">
<subfield code="a">We use expert clinical and public health opinion to estimate likely changes in the prevention and treatment of important disease conditions and how they will affect future life expectancy. Focus groups were held including clinical and public health faculty with expertise in the six leading causes of death in the United States. Mortality rates and life tables for 2040 were derived by sex and age. Life expectancy at age 20 and 65 was compared to figures published by the Social Security Administration and to estimates from the Lee-Carter method. There was agreement among all three approaches that life expectancy at age 20 will increase by approximately one year per decade for females and males between now and 2040. According to the clinical experts, 70% of the improvement in life expectancy will occur in cardiovascular disease and cancer, while in the last 30 years most of the improvement has occurred in cardiovascular disease. Expert opinion suggests that most of the increase in life expectancy will be attributable to the already achieved reduction in smoking rates, especially for women.</subfield>
</datafield>
<datafield tag="650" ind1=" " ind2="4">
<subfield code="0">MAPA20080579258</subfield>
<subfield code="a">Cálculo actuarial</subfield>
</datafield>
<datafield tag="650" ind1=" " ind2="4">
<subfield code="0">MAPA20080602192</subfield>
<subfield code="a">Investigación clínica</subfield>
</datafield>
<datafield tag="650" ind1=" " ind2="4">
<subfield code="0">MAPA20090007925</subfield>
<subfield code="a">Opinión pública</subfield>
</datafield>
<datafield tag="650" ind1=" " ind2="4">
<subfield code="0">MAPA20080580377</subfield>
<subfield code="a">Esperanza de vida</subfield>
</datafield>
<datafield tag="650" ind1=" " ind2="4">
<subfield code="0">MAPA20080555306</subfield>
<subfield code="a">Mortalidad</subfield>
</datafield>
<datafield tag="651" ind1=" " ind2="1">
<subfield code="0">MAPA20080638337</subfield>
<subfield code="a">Estados Unidos</subfield>
</datafield>
<datafield tag="700" ind1="1" ind2=" ">
<subfield code="0">MAPA20160014174</subfield>
<subfield code="a">Canudas-Romo, Vladimir</subfield>
</datafield>
<datafield tag="773" ind1="0" ind2=" ">
<subfield code="w">MAP20077000239</subfield>
<subfield code="t">North American actuarial journal</subfield>
<subfield code="d">Schaumburg : Society of Actuaries, 1997-</subfield>
<subfield code="x">1092-0277</subfield>
<subfield code="g">05/09/2016 Tomo 20 Número 3 - 2016 , p. 276-285</subfield>
</datafield>
</record>
</collection>